Asthika Goonewardene

Stock Analyst at Truist Securities

(1.43)
# 3,534
Out of 5,044 analysts
92
Total ratings
40.91%
Success rate
-10.62%
Average return

Stocks Rated by Asthika Goonewardene

Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32$39
Current: $18.60
Upside: +109.68%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $88$97
Current: $94.60
Upside: +2.54%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $27.35
Upside: +265.63%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $57.99
Upside: +70.72%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $250$36
Current: $10.59
Upside: +239.94%
Gilead Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $108$127
Current: $120.47
Upside: +5.42%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56$49
Current: $39.99
Upside: +22.53%
Genmab
Jul 8, 2025
Maintains: Buy
Price Target: $45$46
Current: $29.03
Upside: +58.46%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151$155
Current: $106.05
Upside: +46.16%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88$71
Current: $32.12
Upside: +121.05%
Maintains: Buy
Price Target: $14$10
Current: $1.23
Upside: +713.01%
Maintains: Buy
Price Target: $11$10
Current: $1.65
Upside: +506.06%
Maintains: Buy
Price Target: $25$15
Current: $2.31
Upside: +549.35%
Initiates: Buy
Price Target: $35
Current: $19.46
Upside: +79.86%
Maintains: Buy
Price Target: $87$136
Current: $86.70
Upside: +56.86%
Maintains: Buy
Price Target: $18$15
Current: $1.16
Upside: +1,193.10%
Maintains: Buy
Price Target: $5$4
Current: $1.71
Upside: +133.92%
Maintains: Buy
Price Target: $19
Current: $2.45
Upside: +675.51%
Reiterates: Buy
Price Target: $27
Current: $0.90
Upside: +2,894.01%
Reinstates: Hold
Price Target: $120
Current: $19.87
Upside: +503.93%
Maintains: Hold
Price Target: $100$60
Current: $2.09
Upside: +2,770.81%
Maintains: Buy
Price Target: $228$180
Current: $9.27
Upside: +1,841.73%